--- config: sankey: showValues: false linkColor: target width: 800 height: 1000 nodeAlignment: right --- sankey-beta RNA-seq/exome, 2011, 17 2011, Morin 2011, 15 Morin 2011, Tier 1 FL genes, 14 Morin 2011, Tier 2 FL genes, 1 2011, Pasqualucci 2011b, 2 Pasqualucci 2011b, Tier 1 FL genes, 2 WGS, 2016 WGS, 2 2016 WGS, Okosun 2016, 2 Okosun 2016, Tier 1 FL genes, 2 exome, 2017 exome, 22 2017 exome, Krysiak 2017, 22 Krysiak 2017, Tier 2 FL genes, 5 Krysiak 2017, Tier 1 FL genes, 17 WGS, 2021 WGS, 17 2021 WGS, Hubschmann 2021, 17 Hubschmann 2021, Tier 2 FL genes, 15 Hubschmann 2021, Tier 1 FL genes, 2 exome, 2023 exome, 20 2023 exome, Russler-Germain 2023, 20 Russler-Germain 2023, Tier 1 FL genes, 1 Russler-Germain 2023, Tier 2 FL genes, 19

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.